Collectively, these biochemical analyses showed that although SOCS1 fostered tumour-promoting activity in CT26 CRC cells, it preserved its inhibitory action on cytokine and HGF signalling along with its capacity to enhance p53 activation. This evidence concerns the gene SOCS1 and colorectal carcinoma.